The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery

NCT06898814 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Hip Fracture
Anemia

Interventions

DRUG: Ferric Derisomaltose
DRUG: Saline (NaCl 0,9 %) (placebo)

Sponsor

Soren Overgaard

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]